Join us at the American Academy of Neurology Annual Meeting to learn about the latest in autoimmune and genetic neurology testing.
Featuring a full menu of advanced sequencing assays, Mayo Clinic Laboratories’ genetic test offerings for early-onset gastrointestinal disorders can provide diagnostic clarity that enables customized care.
Innovative bile acid malabsorption panel transforms gastrointestinal care - Insights
Mayo Clinic Laboratories has introduced a revolutionary diagnostic test for bile acid malabsorption, a significant contributor to chronic diarrhea. Developed by Dr. Michael Camilleri and Dr. Leslie Donato, this new bile acid malabsorption...
People Archives - Page 30 of 35 - Insights
Skip to Content MayoACCESS MayoLINK...
Skip to Content MayoACCESS MayoLINK...
The Metabolic Autopsy: Postmortem Screening in Cases of Sudden, Unexpected Death - Insights
In cases of sudden or unexpected death, autopsy evaluation can include a biochemical analysis to identify deaths caused by fatty acid oxidation disorders.
Gadolinium-based contrast agents (GBCAs) have revolutionized MRIs by increasing the clinical utility and detection sensitivity of these exams. GBCAs also contain gadolinium, a rare earth metal with unique chemical properties. This article...
Antifungal Drug Susceptibility Testing of Yeast: A Primer for Beginners - Insights
In this month’s “Hot Topic,” Nancy Wengenack, Ph.D., discusses susceptibility testing of yeast for those who are considering performing it in their laboratory, perhaps for the first time, or for those who choose to send their yeast isolates...
Pathways Case Studies: March 2023 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for March include the following sub-specialties: Breast Pathology, Cytopathology,...
New Eligibility Guidelines for Blood Donors with Previous Cancer Diagnoses - Insights
To coincide with American Red Cross recommendations, the Mayo Clinic Blood Donor Program has redefined eligibility guidelines for donors who have had a history of previous cancer diagnoses.